Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists

N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists

US Patent 9822141 · Granted Nov 21, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic amide-containing pyridyl xanthines as A2B antagonists2025
Cyclic amide-containing pyridyl xanthines as A2B antagonists2023
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonists2017
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists2015
Methods for the synthesis of unsymmetrical cycloakyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloakyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines2013
Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines2013